$50,000 Pediatric Device Innovation Grant Awarded to Procyrion, Inc. - KSLA News 12 Shreveport, Louisiana News Weather & Sports

$50,000 Pediatric Device Innovation Grant Awarded to Procyrion, Inc.

Posted: Updated:
  • KSLA News 12 HeadlinesMore>>

  • Lights at Haughton roadside memorial trashed, replaced

    Lights at Haughton roadside memorial trashed, replaced

    Wednesday, July 30 2014 11:14 PM EDT2014-07-31 03:14:41 GMT
    Missing items from a roadside memorial to an ArkLaTex girl who lost her life near the site has her family shocked and outraged.More >>
    Missing items from a roadside memorial to an ArkLaTex girl who lost her life near the site has her family shocked and outraged.More >>
  • South BC developer scraps subdivision plan, oil and gas company buys land

    South BC developer scraps subdivision plan, oil and gas company buys land

    Wednesday, July 30 2014 11:03 PM EDT2014-07-31 03:03:46 GMT
    Plans for a plot of land originally slated for a new subdivision in South Bossier City have been scratched, and while some neighbors are pleased to hear that, they aren't necessarily convinced that the replacement plan will be any better.More >>
    Plans for a plot of land originally slated for a new subdivision in South Bossier City have been scratched, and while some neighbors are pleased to hear that, they aren't necessarily convinced that the replacement plan will be any better.More >>
  • Landslide hits Indian village, killing at least 18

    Landslide hits Indian village, killing at least 18

    Wednesday, July 30 2014 10:49 PM EDT2014-07-31 02:49:32 GMT
    An Indian official says that more than 150 people are feared buried under a landslide that hit a village in western India following torrential rains.More >>
    Rescuers worked in rain Thursday to dig through a remote village in western India where at least 21 people died as a landslide swept away scores of houses, possibly trapping many more people under debris, officials said.More >>
Procyrion Life Science Entrepreneurs Configuring Aortix™ Pump For Pediatric Use

HOUSTON, TX. Procyrion, Inc., a medical device firm developing the first catheter-deployed circulatory assist device intended for long-term use in the treatment of chronic heart failure, has been awarded a $50,000 grant from the National Capital Consortium for Pediatric Device Innovation. The award, part of the FDA Pediatric Device Consortia grant program, presented five innovators with up to $50,000 each to bring their technology projects to life.

Procyrion’s Aortix™ is a small, continuous-flow pump mounted within a self-expanding anchoring system and delivered via catheter through the femoral artery to the descending thoracic aorta. Once the catheter sheath is pulled back, nickel-titaniumanchors deploy to anchor the pump to the aortic wall. Aortix functions by accelerating a portion of the native aortic flow, resulting in reduced work of the heart and increased blood flow to vital organs.

In partnership with Maxon Precision Motors, Inc. (Fall River, MA), grant funds are being used to modify the adult Aortix device for use in children born with single ventricle heart defects. “The commercialization path of pediatric medical devices presents unique challenges due to limited market size; maxon precision motors is proud to help meet those challenges and work with Procyrion to develop an efficacious tool for this important unmet clinical need,” said Christopher Blake, president of maxon precision motors, inc.

In order to optimize the circulatory assist device for pediatric use, maxon precision motors is donating a supply of modified motors and engineering support to the project. In addition to adapting the device to fit a child, the Procyrion team has already begun optimizing the flow profile needed to clinically manage single ventricle physiologies associated with the Fontan procedure.

“Many devices for adults are not suitable for pediatric use, but the small form factor of Aortix makes it very useful for the pediatric patient. With minor modifications, we hope to create a first-in-class device for pediatric patients with failing Fontan circulation. Receiving this grant reflects confidence our product can impact the underserved pediatric medical device market,” said Ben Hertzog, president and CEO of Procyrion.

Procyrion is also working with Dr. Charles Fraser, Chief of Congenital Heart Surgery and Cardiac Surgeon-In-Charge, and Dr. Daniel Penny, Chief of Pediatric Cardiology, at Texas Children’s Hospital to help ensure this early work leads to a clinically useful device. “This is a promising technology with many potential applications,” said Dr. Fraser. “I am excited about its potential and look forward to working together with Procyrion to develop those applications.”

The NCC-PDI Review Committee and Pediatric Device Development Panel selected winners based on clinical significance of the pediatric device, approach to product development, likelihood of being marketed successfully, project team, environment, resources, and potential for additional funding.

The program also places special emphasis on helping bridge the gap that often follows the prototyping phase, as the promising medical device must also be manufactured, cleared by the FDA, marketed, and sold.

ABOUT PROCYRION

Houston-based medical device firm Procyrion, Inc. is developing the first catheter-deployed, intra-aortic pump for ambulatory use. The device is designed to rest and heal the heart by reducing afterload while simultaneously improving blood flow to vital organs. This groundbreaking cardiology tool, conceived by cardiologist Dr. Reynolds M. Delgado, III, medical director of Mechanical Support Devices in Heart Failure at the Texas Heart Institute, is expected to provide a minimally invasive treatment option for millions of chronic heart failure patients. For more information, visit www.procyrion.com or call 713.579.9227.

Media Contact
Company Name: Procyrion, Inc.
Contact Person: Anna Drake
Email: Send Email
Phone: 713.510.0500
Address:3900 Essex Lane Suite 575
City: Houston
State: TX
Country: United States
Website: www.procyrion.com

Source: www.abnewswire.com

ReleaseID: 13059

Powered by WorldNow